Oblique Therapeutics

We are specialized in mechanisms of cancer and committed to developing novel antibody medicines for cancer immunotherapy. ABBA Therapeutics is a privately owned Swiss biopharmaceutical company based in Basel. Mission: ABBA Therapeutics is dedicated to serving more cancer patients to benefit from immunotherapies with novel medicines. Vision: ABBA Therapeutics aims to become a leading biopharmaceutical company specialized and focused on the discovery and development of biologics for the treatment of immune-related disorders. About our company and what we are standing for.

We are committed to finding new therapeutic solutions for patients fighting infections, searching for first-in-class pathogen-specific compounds with novel mechanisms of action. ABAC Therapeutics team is committed to finding innovative therapeutic solutions to protect the lives of patients infected with AMR, and fight one of the most serious global health crises, the "silent pandemic", in addition to promote a paradigm shift in the treatment of infectious diseases in general, through selective antibiotics and precision medicine to safeguard people's lives and well-being.The ABAC team is supported by a consortium of collaborators and partners committed to the company's objectives. A multidisciplinary team of experts and advisers with knowledge and entrepreneurial vision, targeted at productivity and delivery. ABAC Therapeutics is committed to disruptively innovating in products and in drug discovery strategy. PasNas is a highly scalable and multiplexed platform that is adaptable to compounds of any chemical nature and can be applied against any target and bacterial species.

We are here to make a difference by investing in the future of healthcare. Abliva is a Swedish drug development company based in Lund…. Alex Therapeutics is a digital therapeutics (DTx) company based in Stockholm…. Arthex Biotech is a Spanish biopharmaceutical company developing advanced RNA treatments…. Attgeno is a pharmaceutical company based in Stockholm, Sweden…. CardioMech AS is a privately-held Norwegian company that develops an innovative technology…. Cardior Pharmaceuticals is a leading clinical-stage biopharmaceutical company…. Complement Therapeutics GmbH is a German headquartered biotechnology company….

We are a science-driven biopharmaceutical start-up on a mission to deliver innovative antibody based medicines for the treatment of immune disorders and inflammatory diseases. Towards better medicines for the treatment of Alzheimer’s disease We are committed to discovering and developing novel antibody drugs to combat neurodegenerative diseases.

Ablevia's team envisions a future where the targeted removal of unwanted and disease-causing antibodies no longer imposes inefficient and stressful restrictions. Our mission is to offer a therapeutic principle for removing disease-causing and drug-neutralizing antibodies specifically and rapidly for the benefit of our partners, customers and patients. Ablevia has developed a proprietary platform technology enabling the efficient and selective sequestration of harmful antibodies by a new class of infusible biological therapeutics. We are reaching out for programs with strong partners in need of addressing undesired antibodies in preclinical and clinical development. Ablevia's SADC technology target such pre-existing or induced neutralizing antibodies for those patients who would otherwise not be eligible for gene therapy if they carry neutralizing antibodies. Ablevia’s compounds can be adapted to well-defined disease-causing autoantibodies in the emerging field of autoimmune conditions, such as some neuroimmunological diseases. We are a preclinical R&D company, developing a new class of injectable biologics for the removal of harmful antibodies from blood circulation. Ablevia biotech is an innovative R&D company, focused on the targeted depletion of harmful and disease-causing antibodies from blood circulation.

We are developing novel therapeutic antibodies to target a fundamental control pathway associated with cancer and several other major diseases. An innovative biotechnology company based in Edinburgh, Scotland. Our technology has great potential to provide powerful new treatment options to extend and improve lives.